KalVista holder SilverArc reports no remaining stake

KalVista Pharmaceuticals, Inc. received an ownership update from SilverArc Capital Management, LLC and Devesh Gandhi.

Rhea-AI Filing Summary

KalVista Pharmaceuticals, Inc. received an ownership update from SilverArc Capital Management, LLC and Devesh Gandhi. The reporting persons state they now beneficially own 0 shares of the company’s Class A Common Stock, representing 0% of the class. They report no sole or shared voting or dispositive power over any shares and indicate that they are owners of 5 percent or less of this class of securities.

Key Figures

Beneficially owned shares: 0 shares Percent of class owned: 0 % Sole voting power: 0 +1 more

4 metrics

Beneficially owned shares 0 shares Reported beneficial ownership of KalVista Class A Common Stock

Percent of class owned 0 % Reported percentage of KalVista Class A Common Stock

Sole voting power 0 Shares over which the reporting persons have sole voting power

Shared voting power 0 Shares over which the reporting persons have shared voting power

Key Terms

beneficially owned, Sole Voting Power, Shared Dispositive Power, Ownership of 5 percent or less of a class

4 terms

beneficially owned financial

"Amount beneficially owned: 0"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Sole Voting Power financial

"5 | Sole Voting Power 0.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

Shared Dispositive Power financial

"8 | Shared Dispositive Power 0.00"

Ownership of 5 percent or less of a class regulatory

"Ownership of 5 percent or less of a class"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did SilverArc Capital disclose in this Schedule 13G/A for KALV?

SilverArc Capital Management, LLC and Devesh Gandhi disclosed they now beneficially own 0 shares of KalVista Class A Common Stock, representing 0% of the class, with no sole or shared voting or dispositive power.

Does SilverArc Capital still hold a significant stake in KalVista (KALV)?

According to this filing, SilverArc Capital Management, LLC and Devesh Gandhi report beneficial ownership of 0% of KalVista’s Class A Common Stock and confirm ownership of 5 percent or less of the class.

Who are the reporting persons in the KalVista (KALV) Schedule 13G/A amendment?

The reporting persons are SilverArc Capital Management, LLC, a Delaware limited liability company, and Devesh Gandhi, a citizen of the United States, acting together as the reporting group for this ownership statement.

What voting power over KalVista (KALV) shares is reported by SilverArc and Gandhi?

They report 0 shares with sole voting power and 0 shares with shared voting power, and likewise 0 shares with sole or shared dispositive power, indicating no current voting or dispositive authority.

What class of securities does this Schedule 13G/A for KALV cover?

The amendment covers KalVista Pharmaceuticals’ Class A Common Stock, identified by CUSIP number 483497AA1, and reports updated beneficial ownership information for that security class.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/14/2026 - 12:49 PM Accepted by SEC EDGAR 08/14/2026 - 12:48 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

KALVISTA PHARMACEUTICALS, INC.

(Name of Issuer)

Class A Common Stock

(Title of Class of Securities)

483497AA1

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 483497AA1

1

Names of Reporting Persons

SilverArc Capital Management, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP Number(s): 483497AA1

1

Names of Reporting Persons

Devesh Gandhi

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: KALVISTA PHARMACEUTICALS, INC.
(b)	Address of issuer's principal executive offices: 200 Crossing Boulevard, Framingham, MA 01702
Item 2.
(a)	Name of person filing: SilverArc Capital Management, LLC ("SilverArc") and Devesh Gandhi ("Gandhi" and together with SilverArc, the "Reporting Persons")
(b)	Address or principal business office or, if none, residence: 20 Park Plaza, Suite 620 Boston, MA 02116
(c)	Citizenship: SilverArc is a Delaware limited liability company. Gandhi is a citizen of the United States.
(d)	Title of class of securities: Class A Common Stock
(e)	CUSIP No.: 483497AA1
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 0
(b)	Percent of class: 0 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

SilverArc Capital Management, LLC

Signature:	Devesh S. Gandhi
Name/Title:	Sole Member of SilverArc Capital Management, LLC
Date:	08/10/2026

Devesh Gandhi

Signature:	Devesh S. Gandhi
Name/Title:	Sole Member of SilverArc Capital Management, LLC
Date:	08/10/2026